MedKoo Cat#: 466126 | Name: AA29504

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AA29504 is a novel potent agonist and positive allosteric modulator (Ago-PAM) of δ-GABAARs.

Chemical Structure

AA29504
AA29504
CAS#945828-50-2

Theoretical Analysis

MedKoo Cat#: 466126

Name: AA29504

CAS#: 945828-50-2

Chemical Formula: C19H25N3O2

Exact Mass: 327.1947

Molecular Weight: 327.43

Elemental Analysis: C, 69.70; H, 7.70; N, 12.83; O, 9.77

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
AA29504; AA 29504; AA-29504;
IUPAC/Chemical Name
ethyl (2-amino-4-((2,4,6-trimethylbenzyl)amino)phenyl)carbamate
InChi Key
SCOOTUMXCXKEAD-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H25N3O2/c1-5-24-19(23)22-18-7-6-15(10-17(18)20)21-11-16-13(3)8-12(2)9-14(16)4/h6-10,21H,5,11,20H2,1-4H3,(H,22,23)
SMILES Code
O=C(OCC)NC1=CC=C(NCC2=C(C)C=C(C)C=C2C)C=C1N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 327.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sikstus S, Benkherouf AY, Soini SL, Uusi-Oukari M. The Influence of AA29504 on GABAA Receptor Ligand Binding Properties and Its Implications on Subtype Selectivity. Neurochem Res. 2022 Mar;47(3):667-678. doi: 10.1007/s11064-021-03475-y. Epub 2021 Nov 2. PMID: 34727270; PMCID: PMC8847198. 2: McGrath M, Tolia M, Raines DE. The effects of a competitive antagonist on GABA-evoked currents in the presence of sedative-hypnotic agents. Pharmacol Rep. 2020 Feb;72(1):260-266. doi: 10.1007/s43440-019-00031-y. Epub 2020 Jan 8. PMID: 32016849; PMCID: PMC7006677. 3: Olander ER, Madjroh N, Bunch L, Söderhielm PC, Jensen AA. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors. Biochem Pharmacol. 2018 Apr;150:305-319. doi: 10.1016/j.bcp.2018.02.015. Epub 2018 Feb 16. PMID: 29454619. 4: Falk-Petersen CB, Søgaard R, Madsen KL, Klein AB, Frølund B, Wellendorph P. Development of a Robust Mammalian Cell-based Assay for Studying Recombinant α4 β1/3 δ GABAA Receptor Subtypes. Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):119-129. doi: 10.1111/bcpt.12778. Epub 2017 May 25. PMID: 28299900. 5: Vardya I, Hoestgaard-Jensen K, Nieto-Gonzalez JL, Dósa Z, Boddum K, Holm MM, Wolinsky TD, Jones KA, Dalby NO, Ebert B, Jensen K. Positive modulation of δ-subunit containing GABA(A) receptors in mouse neurons. Neuropharmacology. 2012 Sep;63(3):469-79. doi: 10.1016/j.neuropharm.2012.04.023. Epub 2012 Apr 30. PMID: 22579928. 6: Hoestgaard-Jensen K, Dalby NO, Wolinsky TD, Murphey C, Jones KA, Rottländer M, Frederiksen K, Watson WP, Jensen K, Ebert B. Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors. Neuropharmacology. 2010 Mar-Apr;58(4-5):702-11. doi: 10.1016/j.neuropharm.2009.12.023. Epub 2010 Jan 12. PMID: 20060846.